Position in VTRS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,890
+$1,675 QoQ
Shares Held
182
+102.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#863
of 1,016 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HFM Investment Advisors, LLC holds $15,496 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
8 | $4,334 | |
| 2 | VTRS |
Viatris Inc
This page
|
182 | $2,890 | |
| 3 | ZTS |
Zoetis Inc.
|
27 | $1,940 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
75 | $1,845 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10 | $1,685 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
8 | $887 | |
| 7 | ALKS |
Alkermes plc.
|
16 | $838 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24 | $415 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,890 | 182 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,215 | 90 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $921 | 74 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $574 | 58 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $589 | 66 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $121 | 14 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||